Expert Comparison: Cost, Effectiveness & Value Analysis
Which Is Better Mounjaro or Wegovy: The Complete UK Price Comparison
When evaluating which is better Mounjaro or Wegovy from a cost perspective, the difference is substantial. Wegovy (semaglutide) operates as a single GLP-1 receptor agonist, while Mounjaro (tirzepatide) combines GIP and GLP-1 mechanisms as a dual agonist. At EverydayMeds, this translates to different pricing structures that can significantly impact your monthly treatment budget.
Our Wegovy pricing starts from £79.99 for the 0.25mg starter dose, progressing to £209.99 for the 2.4mg maintenance dose. Mounjaro typically costs more due to its newer dual-action formulation, though both remain prescription-only medicines requiring clinical assessment. The question of which is better Mounjaro or Wegovy often comes down to individual response and budget considerations, making EverydayMeds' transparent pricing crucial for informed decision-making.
Wegovy Pricing Structure: Bundles and Savings Breakdown
Understanding which is better Mounjaro or Wegovy requires examining the total treatment cost over time. Our Wegovy single pens range from £79.99 (0.25mg starter) to £209.99 (2.4mg maintenance), with strategic bundle options designed for convenience rather than just savings. The Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing your first 8 weeks of treatment in one order with assured cold-chain delivery.
For longer-term planning, our Ultimate Stability Trio delivers three months of 2.4mg maintenance doses for £649.99, ensuring uninterrupted treatment without multiple orders. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 — these codes are already factored into our published prices. When considering which is better Mounjaro or Wegovy, these structured pricing options make Wegovy more accessible for sustained weight management alongside a reduced-calorie diet and increased physical activity.
Clinical Evidence: How Mounjaro and Wegovy Compare in Trials
Determining which is better Mounjaro or Wegovy requires understanding their distinct clinical profiles rather than direct comparisons. Wegovy's STEP trials, particularly the landmark study by Wilding et al. (NEJM, 2021), demonstrated that patients achieved approximately 15% average weight loss at 68 weeks when used alongside lifestyle modifications. The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials indicated different outcomes, but comparing these directly would be misleading due to varying trial designs, patient populations, and endpoints. Both medications have shown significant efficacy in clinical settings, suggesting that which is better Mounjaro or Wegovy may depend more on individual factors like tolerability, injection preferences, and cost considerations than on trial-to-trial comparisons.
Understanding Wegovy's Mechanism for Informed Choice
When evaluating which is better Mounjaro or Wegovy, understanding how Wegovy works helps inform your decision. Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking a natural hormone that signals fullness to your brain after eating. This mechanism reduces appetite and promotes satiety with smaller meals, potentially decreasing food cravings by working directly on brain appetite centres. The once-weekly FlexTouch pen delivers consistent medication levels, supporting appetite regulation throughout the week. Unlike Mounjaro's dual GIP/GLP-1 action, Wegovy's singular GLP-1 focus provides a well-established mechanism with extensive clinical data. This targeted approach may suit patients who respond well to GLP-1 stimulation alone, making it a cost-effective choice for many seeking weight management support.
EverydayMeds Ordering: Streamlined Process for Both Options
Regardless of which is better Mounjaro or Wegovy for your situation, our ordering process ensures professional care at competitive prices. Your journey begins with a comprehensive 3-minute online clinical assessment, covering medical history, current medications, and weight management goals to determine suitability. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), evaluating whether Wegovy, Mounjaro, or an alternative approach best suits your needs. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) handles every step professionally, from clinical review to doorstep delivery. This streamlined process means you're never left wondering about your treatment timeline or medication quality.
Storage and Practical Considerations for Daily Use
Storage requirements often influence which is better Mounjaro or Wegovy for individual lifestyles. Wegovy requires refrigeration at 2-8°C before first use but offers a significant advantage with 6 weeks of room temperature stability below 30°C once removed from the fridge. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy more suitable for frequent travellers or those with storage concerns. The FlexTouch pen design provides intuitive dose delivery with clear dosing windows and audio clicks for confirmation. Wegovy's mandatory dose escalation follows a specific schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This gradual increase helps minimise side effects while optimising therapeutic benefits alongside your reduced-calorie diet and exercise programme.
Which Is Better Mounjaro or Wegovy: UK Cost-Effectiveness Analysis
The cost-effectiveness equation for which is better Mounjaro or Wegovy extends beyond initial pricing to include consultation fees, prescription charges, and ongoing support. At EverydayMeds, our inclusive pricing model combines clinical assessment, prescriber review, prescription generation, and medication supply into one transparent cost. Many UK providers charge separately for consultations (£30-50), prescription fees (£20-40), and medication, creating hidden costs that inflate your actual treatment expense.
Our bundle approach eliminates these surprises while providing flexibility for different treatment phases. Whether you choose the Intro Trio for initial dose escalation at £299.99 or individual pens as needed, you're receiving comprehensive care without additional consultation fees. This integrated model makes professional weight management support accessible while maintaining the clinical oversight required for prescription-only medicines, regardless of which is better Mounjaro or Wegovy for your specific circumstances.
Start Your Weight Management Journey Today
The decision of which is better Mounjaro or Wegovy ultimately depends on your individual needs, medical history, and budget preferences — factors our prescribers evaluate during your clinical assessment. Both treatments are available through EverydayMeds with the same professional care, competitive pricing, and next-day delivery service. New customers can begin their journey using code FIRST40 at checkout, while returning patients apply DOSE25 for continued savings. Our transparent pricing, comprehensive support, and GPhC-registered pharmacy credentials (#9012878) ensure you receive authentic medication with proper clinical oversight. Don't let cost barriers prevent you from accessing professional weight management support — begin your assessment today at https://everydaymeds.co.uk/collections/wegovy and discover which treatment option aligns with your goals and budget.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
